Prescription drug costs remain a heavy burden for many families, with recent research showing that one in five people who filled a prescription in 2025 rationed their medication because of price. While the public often focuses on manufacturers and pharmacy‑benefit managers, a critical part of the price chain begins when a pharmacy purchases medication from a wholesaler.
Technology brings price transparency to the buying process
Traditional ordering required pharmacy staff to check each wholesaler’s catalog separately, often missing lower offers. New software platforms now aggregate electronic cost files from multiple wholesalers onto a single screen, displaying live pricing and inventory levels. This real‑time comparison lets buyers sort offers, place the lowest‑priced order, and reduce the time spent navigating multiple supplier sites.
Researchers at The Ohio State University College of Pharmacy have used Centers for Medicare & Medicaid Services data to illustrate how invoice costs can vary widely between stores, even for the same medication. The disparity is especially pronounced in the generic market, which fills about 90% of prescriptions nationwide, according to the Association for Accessible Medicines.
Independent pharmacies stand to benefit
National chain pharmacies often negotiate better wholesale contracts, leaving independent stores at a disadvantage. Joe Mohamed, president of the Mississippi Independent Pharmacies Association, cites unsustainable reimbursement from pharmacy‑benefit managers as the biggest challenge for his members, noting that Mississippi has lost 55 independent pharmacies since 2021.
By adopting price‑comparison technology, independent owners can gain more control over their acquisition costs. Stacey Swartz, co‑owner of Neighborhood Pharmacy of Del Ray in Alexandria, Virginia, told Drug Topics that the ability to approach cash‑price discounts directly helps her offer competitive prices to patients who pay out of pocket.
How savings affect patients
When a pharmacy purchases a drug at a lower price, the savings often help cover operating expenses rather than directly lowering the copayment set by insurance plans. However, cash‑paying patients may see a reduced price at the counter, especially when pharmacies can match discount‑card offers without incurring additional transaction fees, as noted by healthcare attorney Jesse Dresser.
Greater supply‑chain transparency also equips policymakers with clearer data on wholesale acquisition costs, potentially informing future reforms aimed at reducing overall drug prices.
Looking ahead
Artificial‑intelligence tools are emerging that can analyze a pharmacy’s purchase history to predict optimal ordering times, further minimizing unnecessary spend. As more pharmacies adopt these systems, price visibility could become a standard part of the purchasing process rather than a competitive edge held by a few large chains.
While technology alone won’t solve the broader affordability crisis—policy and insurance design remain major factors—enhanced transparency gives pharmacies a real chance to catch avoidable costs before they reach the patient, preserving access to essential medicines in communities across the country.
Original reporting: KEYT (Ventura/Santa Barbara) — read the source article.
